| Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools |
24 |
| Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis |
17 |
| An optimized prediction framework to assess the functional impact of pharmacogenetic variants |
16 |
| Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis |
13 |
| Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients |
12 |
| The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis |
11 |
| Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drag toxicity |
10 |
| ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia |
10 |
| Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia |
10 |
| Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients |
9 |
| DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A > T: a comprehensive analysis in 1254 patients |
9 |
| Astrocyte-specific transcriptome responses to chronic ethanol consumption |
9 |
| Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells |
8 |
| Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients |
8 |
| Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis |
8 |
| Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis |
8 |
| A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma |
7 |
| Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy |
7 |
| The global spectrum of protein-coding pharmacogenomic diversity |
7 |
| On the readiness of physicians for pharmacogenomics testing: an empirical assessment |
7 |
| Genetic markers in methotrexate treatments |
6 |
| New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation |
6 |
| Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy |
6 |
| Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group |
6 |
| Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease |
6 |
| Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients |
6 |
| Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues |
6 |
| Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention |
5 |
| Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art |
5 |
| Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients |
5 |
| Precision dosing of warfarin: open questions and strategies |
5 |
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine |
5 |
| Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms |
5 |
| Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia |
5 |
| The Influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab |
5 |
| Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis |
5 |
| New polymorphisms associated with response to anti-TNF drugs in patients with moderate-to-severe plaque psoriasis |
5 |
| A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients |
5 |
| Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes |
5 |
| Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases |
5 |
| Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest |
4 |
| Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates |
4 |
| The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro |
4 |
| Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis |
4 |
| The predictive value of ABCB ABCG CYP3A4I5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions |
4 |
| A 6-week laboratory research rotation in pharmacogenomics: a model for preparing pharmacy students to practice precision medicine |
4 |
| Cost-effectiveness of cytochrome P450 2C19*2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome |
4 |
| Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers |
4 |
| An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure |
4 |
| An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor |
4 |
